NGS for Drugs, Patients and Clinical Trials

Next-Generation Sequencing (NGS) is poised to revolutionize the drug discovery paradigm by offering unprecedented interrogation of the human genome at high resolution and relatively low costs. While the widespread implementation of NGS is apparent, issues specific to drug development present new challenges for developers. Join Cambridge Healthtech Institute for NGS for Drugs, Patients and Clinical Trials and explore the unparalleled advantages and arising challenges in using NGS technologies for translational research.

Discussions will cover

• NGS for Decision Making During Drug Development and Clinical Trials
• Developing Informatics Infrastructure & Pipelines to Handle Complex NGS Data
• Navigating Regulatory Hurdles of Informed Consent and Data Sharing
• Harnessing NGS Technologies for Identification of Causal Variants and "Driver" Mechanisms in Disease

Find the full agenda, speaker list and event updates at healthtech.com/ngs-drug-development
Secure your place early to save.